TY - JOUR
T1 - Demographic Trends in New HIV Diagnoses in the U.S., 2009−2013
AU - Bonacci, Robert A.
AU - Holtgrave, David R.
N1 - Funding Information:
RAB was supported by the Center of Excellence for Diversity in Health Education and Research at the University of Pennsylvania. Funding agencies did not participate in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.
Publisher Copyright:
© 2016 American Journal of Preventive Medicine
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Introduction HIV testing is key to achieving the National HIV/AIDS Strategy goals. A new diagnosis metric evaluated whether testing services are reaching the remaining undiagnosed people living with HIV (PLWH), by subpopulation. Methods Centers for Disease Control and Prevention surveillance data from 2008 to 2013 were obtained for: (1) new HIV diagnoses; (2) HIV prevalence; and (3) percentage of PLWH aware of serostatus. The number of new HIV diagnoses in a given year divided by the number of undiagnosed PLWH in the previous year was determined. Trends were evaluated by calculating net percentage change in this measure from 2009 to 2013 for all new diagnoses and stratified by subpopulation. Analyses were conducted during 2015–2016. Results The proportion of all undiagnosed PLWH who achieve serostatus awareness was 26.0%, 25.9%, 26.1%, 27.7%, and 30.4% from 2009 to 2013, respectively. The absolute net change was 4.3% (5.2% for men and 0.5% for women). There was an absolute net change of 5.0%, 3.1%, and 5.5% for the black, Hispanic, and men who have sex with men communities, respectively. An absolute net change >10% was observed only for those aged 13–24 years (10.9%) and ≥65 years (17.8%), and for men who inject drugs (11.7%). Conclusions The proportion of undiagnosed PLWH who achieve serostatus awareness increased minimally from 2009 to 2013, especially for blacks, Hispanics, and men who have sex with men. Redirecting HIV testing efforts and funds to disproportionately affected communities is essential.
AB - Introduction HIV testing is key to achieving the National HIV/AIDS Strategy goals. A new diagnosis metric evaluated whether testing services are reaching the remaining undiagnosed people living with HIV (PLWH), by subpopulation. Methods Centers for Disease Control and Prevention surveillance data from 2008 to 2013 were obtained for: (1) new HIV diagnoses; (2) HIV prevalence; and (3) percentage of PLWH aware of serostatus. The number of new HIV diagnoses in a given year divided by the number of undiagnosed PLWH in the previous year was determined. Trends were evaluated by calculating net percentage change in this measure from 2009 to 2013 for all new diagnoses and stratified by subpopulation. Analyses were conducted during 2015–2016. Results The proportion of all undiagnosed PLWH who achieve serostatus awareness was 26.0%, 25.9%, 26.1%, 27.7%, and 30.4% from 2009 to 2013, respectively. The absolute net change was 4.3% (5.2% for men and 0.5% for women). There was an absolute net change of 5.0%, 3.1%, and 5.5% for the black, Hispanic, and men who have sex with men communities, respectively. An absolute net change >10% was observed only for those aged 13–24 years (10.9%) and ≥65 years (17.8%), and for men who inject drugs (11.7%). Conclusions The proportion of undiagnosed PLWH who achieve serostatus awareness increased minimally from 2009 to 2013, especially for blacks, Hispanics, and men who have sex with men. Redirecting HIV testing efforts and funds to disproportionately affected communities is essential.
UR - http://www.scopus.com/inward/record.url?scp=84994593522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994593522&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2016.07.006
DO - 10.1016/j.amepre.2016.07.006
M3 - Article
C2 - 27567238
AN - SCOPUS:84994593522
SN - 0749-3797
VL - 51
SP - 1044
EP - 1050
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 6
ER -